Med. Pro Praxi 2009; 6(1): 25-29

Current tobacco control in the Czech Republic

MUDr. Eva Králíková CSc
Ústav hygieny a epidemiologie a Centrum léčby závislosti na tabáku III. interní kliniky, 1. LF UK a VFN, Praha

Tobacco products are not a standard consumer goods: half of its consumers will die because of it 15 years sooner. Tobacco consumption

has to be lowered systematically. Always a complex approach of the whole society is needed not only in frame of a country but globally

– as well as the tobacco epidemic is global. Tobacco control includes high taxes, protection against passive smoking, educational campaigns, total ban of tobacco advertising, large health warnings and available treatment. Except of lowering tobacco related morbidity and mortality does tobacco control support the state economics. According to his/her possibilities each physician should influence politicians and decision makers in this sense.

Keywords: tobacco control, physicians‘ role.

Published: March 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Králíková E. Current tobacco control in the Czech Republic. Med. praxi. 2009;6(1):25-29.
Download citation

References

  1. Peto, et al. Mortality from smoking in developed countries, 2006. www.deathsfromsmoking.net.
  2. WHO Framework Convention on Tobacco Control, www. fctc.org.
  3. Hoffmann D, Hoffmann I. The changing cigarette, 1950-1995. J Toxicol Environ Health 1997; 50(4): 307-364. Go to original source... Go to PubMed...
  4. WHO International Agency for Research on Cancer, Monograph Vol. 83. Tobacco Smoke and Involuntary Smoking, WHO IARC, Lyons, 2004: 1452 s.
  5. Hirayama T. Non-smoking wives of heavy smokers have a higher risk of lung cancer: a study from Japan. Br. Med. J. 1981. citováno in Bull. World Health Organ. 2000; 78(7): 940-942. Go to PubMed...
  6. Barnoya J, Glantz SA. Cardiovascular effects of secondhand smoke: nearly as large as smoking, Circulation 2005; 111(20): 2684-2698. Go to original source... Go to PubMed...
  7. Pell JP, et al. Smoke-free Legislation and Hospitalizations for Acute Coronary Syndrome. New England Journal of Medicine 2008; 359(5): 482-491. Go to original source... Go to PubMed...
  8. Cesaroni G, Forastiere F, Agabiti N, Valente P, Zuccaro P, Perucci CA. Effect of the Italian Smoking Ban on Population Rates of Acute Coronary Event, Circulation 2008; 117: 1183-1188. Go to original source... Go to PubMed...
  9. Juster HR, Loomis BR, Hinman TH, Farrelly MC, Hyland A, Bauer UE, Guthrie GS, Birkhead GS. Declines in Hospital Admissions for Acute Myocardial Infarction in New York State After Implementation of a Comprehensive Smoking Ban. Am J Public Health 2007; 97(11): 2035-2039. Go to original source... Go to PubMed...
  10. Ravens MK, Burkhart PV, Zhang M, Lee S, Moser DK, Mannino D, Hahn EJ. Reduction in asthma-related emergency department visits after implementation of a smoke-free law. Journal of Allergy and Clinical Immunology 2008; 122(3): 537-541. Go to original source... Go to PubMed...
  11. WHO International Statistical Classification of Diseases and Related Health Problems, 10th Revision (ICD-10), WHO, Geneva, 1992.
  12. International Primary Care Respiratory Group: Tackling the Smoking Epidemic, www.icprg.org (český překlad Štěpánková L, dostupný na www.slzt.cz v sekci Odborná doporučení).
  13. Fiore MC, Bailey WC, Cohen SJ, et al. Treating tobacco use and dependence: clinical practice guideline. Rockville, MD, US Department of Health and Human Services, 2008.
  14. Latchem S, MacLean Steel K. Workplace interventions to promote smoking cessation. NICE Guidance, http://www.nice.org.uk/Guidance/PH5.
  15. Workplace interventions to promote smoking cessation: costing template (simplified business case for employers). NICE (UK), http://www.nice.org.uk/nicemedia/pdf/PHI5SimplifiedBusinessCase.htm.
  16. Cahill K, Moher M, Lancaster T. Workplace interventions for smoking cessation. Cochrane Database Syst Rev. 2008; (4): CD003440. Go to original source...
  17. Joossens L, Raw M. Progress in Tobacco Control in 30 European Countries 2005 to 2007, presented at the 4th European Conference Tobacco or Health, Basel, Switzerland, 11-13 October 2007, Swiss Cancer League, Basel, 2007, 24 stran.




Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.